Literature DB >> 2525359

Heparin, heparan sulfate, smooth muscle cells, and atherosclerosis.

M J Karnovsky1, T C Wright, J J Castellot, J Choay, J C Lormeau, M Petitou.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2525359     DOI： 10.1111/j.1749-6632.1989.tb22509.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  5 in total

1.  Nitric oxide degradation of heparin and heparan sulphate.

Authors:  R E Vilar; D Ghael; M Li; D D Bhagat; L M Arrigo; M K Cowman; H S Dweck; L Rosenfeld
Journal:  Biochem J       Date:  1997-06-01       Impact factor: 3.857

2.  Inhibition of phosphatidylinositol 4-phosphate kinase by heparin. A possible mechanism for the antiproliferative effects of heparin.

Authors:  C D Smith; D Wen; S L Mooberry; K J Chang
Journal:  Biochem J       Date:  1992-02-01       Impact factor: 3.857

3.  Cell cycle-dependent regulation of elastin gene in cultured chick vascular smooth-muscle cells.

Authors:  H Wachi; Y Seyama; S Yamashita; S Tajima
Journal:  Biochem J       Date:  1995-07-15       Impact factor: 3.857

Review 4.  Mechanisms simultaneously regulate smooth muscle proliferation and differentiation.

Authors:  Ning Shi; Shi-You Chen
Journal:  J Biomed Res       Date:  2013-12-28

Review 5.  Complex carbohydrates in drug development.

Authors:  R L Schnaar
Journal:  Adv Pharmacol       Date:  1992
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.